Braidwell »

Cg Oncology shares owned by Braidwell

Quarter-by-quarter ownership of Cg Oncology shares owned by Braidwell from 13F filings

Historical chart of Braidwell investment in Cg Oncology

Tip: Access up to 7 years of quarterly data

All positions including Cg Oncology held by Braidwell consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cg Oncology by Braidwell

Quarter filed Position value Share count Share price at filing
2024-03-31 $50M 1.1M 43.90

More positions owned by Braidwell

Guardant Health Note11/1 (Principal)
Bridgebio Pharma Note 2.500% 3/1 (Principal)
Exact Sciences Corp Note 0.375% 3/0 (Principal)
Novocure Note11/0 (Principal)
Apogee Therapeutics (APGE)
Nuvasive Note 0.375% 3/1 (Principal)
Neurocrine Biosciences (NBIX)
Argenx Se Sponsored Adr (ARGX)
Vaxcyte (PCVX)
Neogenomics Note 0.250% 1/1 (Principal)
Dexcom Note 0.250%11/1 (Principal)
Legend Biotech Corp Sponsored Ads (LEGN)
Insmed Note 1.750% 1/1 (Principal)
Insulet Corp Note 0.375% 9/0 (Principal)
Penumbra (PEN)

View all positions for Braidwell

Top funds holding Cg Oncology

BlackRock
Vanguard Group
BVF
Henderson Group
Avidity Partners Management
RA Capital Management
Perceptive Advisors
Braidwell
T. Rowe Price Associates
Franklin Resources
Cormorant Asset Management
Frazier Life Sciences Management
Holocene Advisors
T. Rowe Price Investment Management
Foresite Capital Management V

View all funds holding Cg Oncology